1.Research advances on hydrogen therapy in nervous system diseases.
Yuan HONG ; Sheng CHEN ; Jian-min ZHANG
Journal of Zhejiang University. Medical sciences 2010;39(6):638-643
Oxidative stress plays a pivotal role in the pathogenesis of varied nervous system diseases. Recent studies have demonstrated that hydrogen has selective antioxidative effect. It selectively reduces the hydroxyl radical (*OH) and peroxynitrite (ONOO(-)), the most cytotoxic of reactive oxygen species (ROS); however, it does not affect other ROS, which play important physiological roles at low concentrations. A large body of experimental studies has proved that hydrogen, through anti-oxidation, anti-inflammatory and inhibiting apoptosis, has a significant therapeutic effect in various neurological diseases, such as ischemia, hypoxia, degeneration and spinal cord contusion. It provides us with a new clinical method for the prevention and treatment of neurological diseases.
Antioxidants
;
pharmacology
;
Humans
;
Hydrogen
;
pharmacology
;
Hydroxyl Radical
;
metabolism
;
Nervous System
;
drug effects
;
metabolism
;
Nervous System Diseases
;
drug therapy
;
metabolism
;
Oxidative Stress
;
drug effects
;
physiology
;
Peroxynitrous Acid
;
metabolism
2.Therapeutic potential of extracellular ATP and P2 receptors in nervous system diseases.
Neuroscience Bulletin 2009;25(1):27-32
Extracellular adenosine 5 inch-triphosphate (ATP) is a key signaling molecule present in the central nervous system (CNS), and now is receiving greater attention due to its role as a messenger in the CNS during different physiological and pathological events. ATP is released into the extracellular space through vesicular exocytosis or from damaged and dying cells. Once in the extracellular environment, ATP binds to the specific receptors termed P2, which mediate ATP effects and are present broadly in both neurons and glial cells. There are P2X, the ligand-gated ionotropic receptors, possessing low affinity for ATP and responsible for fast excitatory neurotransmission, and P2Y, the metabotropic G-protein-coupled receptors, possessing high affinity for ATP. Since massive extracellular release of ATP often occurs after stress, brain ischemia and trauma, the extracellular ATP is considered relating to or involving in the pathological processes of many nervous system diseases. Conversely, the trophic functions have also been extensively described for the extracellular ATP. Therefore, extracellular ATP plays a very complex role in the CNS and its binding to P2 receptors can be related to toxic and/or beneficial effects. In this review, we described the extracellular ATP acting via P2 receptors as a potent therapeutic target for treatment of nervous system diseases.
Adenosine Triphosphate
;
metabolism
;
therapeutic use
;
Animals
;
Extracellular Fluid
;
metabolism
;
Humans
;
Nervous System Diseases
;
drug therapy
;
metabolism
;
Receptors, Purinergic P2
;
physiology
3.Recent progress of potential effects and mechanisms of chlorogenic acid and its intestinal metabolites on central nervous system diseases.
Li-na XING ; Ming-mei ZHOU ; Yun LI ; Xiao-wen SHI ; Wei JIA
China Journal of Chinese Materia Medica 2015;40(6):1044-1047
Chlorogenic acid displays several important roles in the therapeutic properties of many herbs, such as antioxidant activity, antibacterial, antiviral, scavenging free radicals and exciting central nervous system. Only about one-third of chlorogenic acid was absorbed in its prototype, therefore, its gut metabolites play a more important role in the therapeutic properties of chlorogenic acid. It is necessary to consider not only the bioactivities of chlorogenic acid but also its gut metabolites. This review focuses on the potential activities and mechanisms of chlorogenic acid and its gut metabolites on central nervous system diseases.
Animals
;
Central Nervous System Diseases
;
drug therapy
;
metabolism
;
Chlorogenic Acid
;
administration & dosage
;
metabolism
;
Humans
;
Intestines
;
drug effects
;
metabolism
4.Role of Brain Inflammation in Epileptogenesis.
Yonsei Medical Journal 2008;49(1):1-18
Inflammation is known to participate in the mediation of a growing number of acute and chronic neurological disorders. Even so, the involvement of inflammation in the pathogenesis of epilepsy and seizure-induced brain damage has only recently been appreciated. Inflammatory processes, including activation of microglia and astrocytes and production of proinflammatory cytokines and related molecules, have been described in human epilepsy patients as well as in experimental models of epilepsy. For many decades, a functional role for brain inflammation has been implied by the effective use of anti-inflammatory treatments, such as steroids, in treating intractable pediatric epilepsy of diverse causes. Conversely, common pediatric infectious or autoimmune diseases are often accompanied by seizures during the course of illness. In addition, genetic susceptibility to inflammation correlated with an increased risk of epilepsy. Mounting evidence thus supports the hypothesis that inflammation may contribute to epileptogenesis and cause neuronal injury in epilepsy. We provide an overview of the current knowledge that implicates brain inflammation as a common predisposing factor in epilepsy, particularly childhood epilepsy.
Animals
;
Blood-Brain Barrier
;
Chronic Disease
;
Encephalitis/genetics/immunology/metabolism/*pathology
;
Epilepsy/immunology/metabolism/*pathology/therapy
;
Gene Expression Regulation
;
Humans
;
Nervous System Diseases/immunology/pathology
5.Advance in studies on pharmacological effect of salidroside on nervous system diseases.
China Journal of Chinese Materia Medica 2012;37(17):2505-2509
Salidroside is an extract from Rhodiola crenulata as well as one of major active constituents. In studies of recent years, salidroside showed multiple effects in protecting nerves, scavenging free radicals, regulating central nervous system neurotransmitter, increasing the ability to promote nerve repair and modulating of apoptosis-related gene expression. Hence, it is expected to be applied in treating degenerative nerve diseases and brain ischemic diseases. This essay summarizes studies on pharmacological effects of salidroside on nerve system diseases, providing reference for further studies, development and application of R. crenulata.
Animals
;
Apoptosis Regulatory Proteins
;
genetics
;
metabolism
;
Drugs, Chinese Herbal
;
pharmacology
;
Glucosides
;
pharmacology
;
Humans
;
Nervous System Diseases
;
drug therapy
;
genetics
;
metabolism
;
Phenols
;
pharmacology
;
Rhodiola
;
chemistry
6.Neurorestoration Induced by Mesenchymal Stem Cells: Potential Therapeutic Mechanisms for Clinical Trials.
Yonsei Medical Journal 2012;53(6):1059-1067
Stem cells are emerging as therapeutic candidates in a variety of diseases because of their multipotent capacities. Among these, mesenchymal stem cells (MSCs) derived from bone marrow, umbilical cord blood or adipose tissue, comprise a population of cells that exhibit extensive proliferative potential and retain the ability to differentiate into multiple tissue-specific lineage cells including osteoblasts, chondrocytes, and adipocytes. MSCs have also been shown to enhance neurological recovery, although the therapeutic effects seem to be derived from an indirect paracrine effect rather than direct cell replacement. MSCs secrete neurotrophic factors, promote endogenous neurogenesis and angiogenesis, encourage synaptic connection and remyelination of damaged axons, decrease apoptosis, and regulate inflammation primarily through paracrine actions. Accordingly, MSCs may prevail as a promising cell source for cell-based therapy in neurological diseases.
Cell Differentiation/physiology
;
Clinical Trials as Topic
;
Humans
;
Mesenchymal Stem Cell Transplantation
;
Mesenchymal Stromal Cells/*cytology/physiology
;
Models, Biological
;
Nervous System Diseases/metabolism/*therapy
;
Neurogenesis/physiology
;
Tissue Therapy/methods
7.Effects of hepatic insulin gene therapy on enteric neuropathy in STZ-diabetic mice.
Shuo YOU ; Qing ZHANG ; Mallappa ANITHA ; Dingwu JIA ; Darin E OLSON ; Shanthi SRINIVASAN ; Peter M THULÉ ; Zhiguang ZHOU
Journal of Central South University(Medical Sciences) 2011;36(6):546-553
OBJECTIVE:
To evaluate the effect of hepatic insulin gene therapy on diabetic enteric neuropathy.
METHODS:
Mice were randomly allocated into 3 groups: a normal control group, a diabetic group, and a diabetic gene therapy group. Diabetes were induced by penial vein injection of streptozocin (STZ). The gene therapy group received hepatic insulin gene therapy while the other 2 groups only received an empty virus expressing green fluorescent protein. Random blood glucose, body weight growth, gastric emptying, total bowel length, absolute and relative bowel transit, electric field stimulation of colon smooth muscle, colon nuclei staining and counting were measured.
RESULTS:
We successully established a mouse model of diabetic enteric neuropathy which manifests as: 8 weeks of continuous hyperglycemia,increased total bowel length, decreased relative bowel transit, impaired colon smooth muscle relaxation and loss of inhibitory neurons in colon. Through gene therapy, the above indexes were normalized or ameliorated, suggesting hepatic insulin gene therapy is capable of preventing diabetic enteric neuropathy.
CONCLUSION
Hepatic insulin gene therapy can prevent STZ induced diabetic enteric neuropathy.
Adenoviridae
;
Animals
;
Diabetes Mellitus, Experimental
;
complications
;
therapy
;
Diabetic Neuropathies
;
therapy
;
Enteric Nervous System
;
metabolism
;
pathology
;
Gastrointestinal Diseases
;
etiology
;
therapy
;
Gene Transfer Techniques
;
Genetic Therapy
;
Genetic Vectors
;
Hepatocytes
;
metabolism
;
Insulin
;
genetics
;
metabolism
;
Mice
;
Proinsulin
;
genetics
8.Research advances in brain-targeted nanoscale drug delivery system.
Acta Pharmaceutica Sinica 2013;48(10):1532-1543
The blood-brain barrier (BBB) exerts its central nervous system (CNS) protective function as it hinders the delivery of diagnostic and therapeutic agents to the brain. With the development of nanotechnology during the last thirty years, the nanocarriers for delivering drugs make it possible to transport drugs across the BBB. The brain-targeted drug delivery system usually consists of two parts: nanocarriers and brain-targeted strategies. In this review, several kinds of nanocarriers are introduced for brain-targeted drug delivery. We focus on several possible strategies for brain-targeting and comment on their advantages and disadvantages in application.
Animals
;
Biological Transport
;
Blood-Brain Barrier
;
Brain
;
drug effects
;
metabolism
;
Central Nervous System Agents
;
administration & dosage
;
therapeutic use
;
Central Nervous System Diseases
;
diagnosis
;
drug therapy
;
Drug Carriers
;
Drug Delivery Systems
;
methods
;
Humans
;
Nanoparticles
9.Advance in studies of Panax notoginseng saponins on pharmacological mechanism of nervous system disease.
Ping SU ; Lei WANG ; Shi-Jing DU ; Wen-Feng XIN ; Wen-Sheng ZHANG
China Journal of Chinese Materia Medica 2014;39(23):4516-4521
The pharmacological mechaisms of Panax notoginseng saponins on nervous system diseases (Alzheimer's disease, Parkinson's disease, ischermic cerebral apoplexy and depressive disorder) , including panax notoginseng saponins, protoparaxotriol saponins, panasadiol saponins, ginsenoside Rg1, ginsenoside Rb1, ginsenoside Re and notoginsenoside R1 were summarized to analyze the study hotspots and potential advantages (such as estrogen-like effect) of notoginsenoside's pharmacological actions, provide reference for further pharmacological studies and new ideas for clinical treatment of nervous system diseases and drug studies and development.
Animals
;
Drugs, Chinese Herbal
;
administration & dosage
;
Gene Expression
;
drug effects
;
Humans
;
Nervous System Diseases
;
drug therapy
;
genetics
;
metabolism
;
Panax notoginseng
;
chemistry
;
Saponins
;
administration & dosage
10.Mechanism of electroacupuncture on "Zusanli (ST 36)" for chemotherapy-induced peripheral neuropathy.
Minghong SUI ; Sherrie LESSANS ; Tiebin YAN ; Dongyuan CAO ; Lixing LAO ; Susag G DORSEY
Chinese Acupuncture & Moxibustion 2016;36(5):512-516
OBJECTIVETo observe the effects and duration of electroacupuncture on the mechanical pain threshold induced by paclitaxel and explore its analgesic mechanism.
METHODSSixty-four C57BL/6J male mice were randomly divided into 4 groups, a normal+sham EA group, a normal+EA group, a medicine+sham EA(Med+ sham EA) group, a medicine + EA (Med + EA) group, 16 cases in each group. The model of chemotherapy-induced peripheral neuropathy was established with paclitaxel intraperitoneal injection on the 1st, 3rd, 5th, 7th day in the Med + sham EA group and the Med + EA group. EA of 30 min was used on bilateral "Zusanli (ST 36)" on the 9th, 11th, 13th, 16th, 18th, 20th, 23rd, 25th, 27th, 30th day in the EA groups, 2 Hz/100 Hz and 1~ 1.5 mA. Acupuncture was applied on the same acupoint at the same times in the sham EA groups. Mechanical pain thresholds were tested by VonFrey before and after model establishment, namely on the 8th, 14th; 21st and, 28th day. The heart blood of 8 mice was drawn quickly to collect serum in every group on the 31st day, and the contents of tumor necrosis factor α (TNF-α), interleukin-1α (IL-1α), interleukin-1β (IL-1β) in proinflammatory cytokine were examined by ELISA. Mechanical pain thresholds were tested by VonFrey for the rest 8 mice of each group until there was no apparent difference in the two paclitaxel groups once a week,namely on the 35th, 42nd, 49th day.
RESULTSThe pain thresholds of each group were not statistically different before model establishment (P > 0.05). After model establishment (on the 8th day), thresholds of the paclitaxel groups were lower than those of the normal groups (all P < 0.05). After EA, the mechanical pain thresholds of the Med + EA group were higher than those of the Med + sham EA group at all the time points, and there was statistical difference on the 14th, 21st and 28th day (all P < 0.05). The analgesic effect was lasting to the 49th day. The contents of TNF-α, IL-1α, IL-1β of the Med + EA group were decreased than those of the Med+sham EA group in different degree, with statistical significance of IL-1α (P < 0.05).
CONCLUSIONEA can effectively treat paclitaxel-induced peripheral neuropathy,and the analgesic mechanism is probably related to decreasing the proinflammatory cytokine.
Acupuncture Points ; Animals ; Antineoplastic Agents ; administration & dosage ; adverse effects ; Electroacupuncture ; Humans ; Interleukin-1beta ; genetics ; metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Neoplasms ; drug therapy ; Peripheral Nervous System Diseases ; etiology ; genetics ; metabolism ; therapy ; Tumor Necrosis Factor-alpha ; genetics ; metabolism